TXG Operating Cash Flow (Statement)
10X Genomics Inc Class A · Operating Cash Flow (Statement)
TXG Operating Cash Flow (Statement)
Latest reported$16.97Mperiod ending
TXG Quarterly Cash from Operations (-$10.11M → $16.97M)
Quarterly operating cash flow (statement)
High-resolution chart · PNG
TXG operating cash flow (statement) history
Quarterly · USD. Dates are reporting period ends; fiscal years can differ from calendar years.
| Period ending | Operating Cash Flow (Statement) (USD) |
|---|---|
| 16,974,000 | |
| 26,120,000 | |
| 40,777,000 | |
| 43,214,000 | |
| 17,708,000 | |
| 34,351,000 | |
| -6,748,000 | |
| 21,641,000 | |
| 7,496,000 | |
| -15,725,000 | |
| 25,758,000 | |
| -25,304,000 | |
| -11,526,000 | |
| -4,125,000 | |
| 13,723,000 | |
| -9,564,000 | |
| -16,963,000 | |
| -20,802,000 | |
| 5,805,000 | |
| -26,216,000 | |
| 3,120,000 | |
| -4,082,000 | |
| -130,175,000 | |
| -55,629,000 | |
| -29,518,000 | |
| -2,576,000 | |
| 6,700,000 | |
| 14,526,000 | |
| 4,083,000 | |
| 9,318,000 | |
| -50,999,000 | |
| -5,184,000 | |
| -10,113,000 | |
| -10,113,000 |